Cargando…

The Regulatory Network of METTL3 in the Nervous System: Diagnostic Biomarkers and Therapeutic Targets

Methyltransferase-like 3 (METTL3) is a typical component of N6-methyladenosine writers that exhibits methyltransferase activity and deposits methyl groups on RNA. Currently, accumulating studies have demonstrated the involvement of METTL3 in the regulation of neuro-physiological and pathological eve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Xiaojuan, Qu, Yi, Mu, Dezhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135467/ https://www.ncbi.nlm.nih.gov/pubmed/37189411 http://dx.doi.org/10.3390/biom13040664

Ejemplares similares

Pericytes in Cerebrovascular Diseases: An Emerging Therapeutic Target
por: Su, Xiaojuan, et al.
Publicado: (2019)

Roles of METTL3 in cancer: mechanisms and therapeutic targeting
por: Zeng, Chengwu, et al.
Publicado: (2020)

Research Progress on the Cardiac Injury from ACE2 Targeting in SARS-CoV-2 Infection
por: Sun, Hao, et al.
Publicado: (2021)

METTL21B is a prognostic biomarker and potential therapeutic target in low-grade gliomas
por: Shu, Xin, et al.
Publicado: (2021)

Analysis of METTL3 and METTL14 in hepatocellular carcinoma
por: Liu, Xiangxiang, et al.
Publicado: (2020)

The Roles of Lpar1 in Central Nervous System Disorders and Diseases
por: Xiao, Dongqiong, et al.
Publicado: (2021)

The Distinct Function and Localization of METTL3/METTL14 and METTL16 Enzymes in Cardiomyocytes
por: Arcidiacono, Orazio Angelo, et al.
Publicado: (2020)

Research Progress on the Role and Mechanism of Action of Activin A in Brain Injury
por: Su, Xiaojuan, et al.
Publicado: (2018)

Could SARS-CoV-2-induced lung injury be attenuated by vitamin D?
por: Xiao, Dongqiong, et al.
Publicado: (2021)

Targeting METTL14 and RNA methylation to treat osteosarcoma
por: Ren, Lili, et al.
Publicado: (2022)

METTL5 serves as a diagnostic and prognostic biomarker in hepatocellular carcinoma by influencing the immune microenvironment
por: Wang, Lei, et al.
Publicado: (2023)

HMGB1 in nervous system diseases: A common biomarker and potential therapeutic target
por: Mao, Di, et al.
Publicado: (2022)

Long Noncoding RNA PVT1 as a Novel Diagnostic Biomarker and Therapeutic Target for Melanoma
por: Chen, Xiangjun, et al.
Publicado: (2017)

METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy
por: Pan, Yasi, et al.
Publicado: (2023)

Trimethylamine-N-oxide: a potential biomarker and therapeutic target in ischemic stroke
por: Liu, Yuan, et al.
Publicado: (2023)

Sirtuin Deacetylases as Therapeutic Targets in the Nervous System
por: Langley, Brett, et al.
Publicado: (2013)

METTL7B serves as a prognostic biomarker and promotes metastasis of lung adenocarcinoma cells
por: Li, Rong, et al.
Publicado: (2022)

Novel insights into the METTL3-METTL14 complex in musculoskeletal diseases
por: Xu, Yeqiu, et al.
Publicado: (2023)

Microglia and Their Promising Role in Ischemic Brain Injuries: An Update
por: Yu, Luting, et al.
Publicado: (2020)

Research Progress on the Role of RNA m6A Modification in Glial Cells in the Regulation of Neurological Diseases
por: You, Siyi, et al.
Publicado: (2022)

B7–H3 as a Prognostic Biomarker and Therapeutic Target in Pediatric central nervous system Tumors
por: Maachani, Uday B., et al.
Publicado: (2019)

Diagnostic Values of METTL1-Related Genes and Immune Characteristics in Systemic Lupus Erythematosus
por: Liu, Yu, et al.
Publicado: (2023)

Emerging role of METTL3 in inflammatory diseases: mechanisms and therapeutic applications
por: Song, Bimei, et al.
Publicado: (2023)

RNA methyltransferase METTL16: Targets and function
por: Satterwhite, Emily R., et al.
Publicado: (2021)

Correction: Novel insights into the METTL3-METTL14 complex in musculoskeletal diseases
por: Xu, Yeqiu, et al.
Publicado: (2023)

Central Nervous System Therapeutic Targets in Friedreich Ataxia
por: Harding, Ian H., et al.
Publicado: (2020)

Editorial for “Regulatory RNAs in the nervous system”
por: Cellerino, Alessandro, et al.
Publicado: (2015)

METTL14-mediated RNA methylation in digestive system tumors
por: Hu, Jiexuan, et al.
Publicado: (2023)

Functions, mechanisms, and therapeutic implications of METTL14 in human cancer
por: Guan, Qian, et al.
Publicado: (2022)

A cleaved METTL3 potentiates the METTL3–WTAP interaction and breast cancer progression
por: Yan, Chaojun, et al.
Publicado: (2023)

The METTL3 RNA Methyltransferase Regulates Transcriptional Networks in Prostate Cancer
por: Haigh, Daisy B., et al.
Publicado: (2022)

Inferencing Bulk Tumor and Single-Cell Multi-Omics Regulatory Networks for Discovery of Biomarkers and Therapeutic Targets
por: Ye, Qing, et al.
Publicado: (2022)

Identification of Serum miRNAs as Effective Diagnostic Biomarkers for Distinguishing Primary Central Nervous System Lymphoma from Glioma
por: Si, Pei-pei, et al.
Publicado: (2022)

The regulatory role of lipophagy in central nervous system diseases
por: Lan, Zhuo-qing, et al.
Publicado: (2023)

The lymphatic system: a therapeutic target for central nervous system disorders
por: Xu, Jia-Qi, et al.
Publicado: (2022)

Mapping of m(6)A and Its Regulatory Targets in Prostate Cancer Reveals a METTL3-Low Induction of Therapy Resistance
por: Cotter, Kellie A., et al.
Publicado: (2021)

Sprouty2—a Novel Therapeutic Target in the Nervous System?
por: Hausott, Barbara, et al.
Publicado: (2018)

Multiple opportunistic central nervous system coinfections in HIV: Diagnostic and therapeutic difficulties
por: Chakraborty, Mandira, et al.
Publicado: (2021)

Novel prognostic biomarkers, METTL14 and YTHDF2, associated with RNA methylation in Ewing’s sarcoma
por: Jiang, Jie, et al.
Publicado: (2022)

HIV Replication Is Increased by RNA Methylation METTL3/METTL14/WTAP Complex Activators
por: Selberg, Simona, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hajve20fo21f02aeilt64el86u